Next, to determine if autophagy induction in tumor cells by anti–PD-1 Ab is a major contributor to the reduced efficacy of anti–PD-1 therapy, CRISPR/Cas9 gene editing was used to knock out an essential autophagy gene Atg7 in B16 cells (Figure 2I). This evidence concerns the gene ATG7 and neoplasm.